Lysophosphatidic acid receptor 5 (LPAR5) is considered a prognosis-related gene for pan cancers, and abnormal high-level expression of LPAR5 confers IR-induced epithelial-to-mesenchymal transition (EMT) and radioresistance to cancer cells [17,70]. This evidence concerns the gene LPAR5 and cancer.